Inventor
KOIKE TATSUKI
JP49 patents
⚠️ This page may combine multiple inventors who share the name “KOIKE TATSUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
34 patentsUS10584097B2Mar 10, 2020
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO14 citations94
US10428023B2Oct 1, 2019
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO22 citations94
US10106556B2Oct 23, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO8 citations83
US9643957B2May 9, 2017
Heterocyclic compounds having cholesterol 24-hydroxylase activity
TAKEDA PHARMACEUTICALS CO6 citations83
US9586930B2Mar 7, 2017
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO3 citations83
US9440990B2Sep 13, 2016
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO7 citations83
US11028048B2Jun 8, 2021
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO8 citations82
US11440883B2Sep 13, 2022
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO3 citations73
US11174272B2Nov 16, 2021
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations73
US10550129B2Feb 4, 2020
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations73
US10273245B2Apr 30, 2019
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations73
US11655241B2May 23, 2023
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO2 citations72
US11319286B2May 3, 2022
Heterocyclic compound and application thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US11059780B2Jul 13, 2021
Substituted pyrrolidine compound and use thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US11034700B2Jun 15, 2021
Substituted pyrrolidine compound and use thereof
TAKEDA PHARMACEUTICALS CO4 citations72
US9624170B2Apr 18, 2017
4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
TAKEDA PHARMACEUTICALS CO3 citations72
US9598398B2Mar 21, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations72
US10548877B2Feb 4, 2020
Aromatic ring compound
TAKEDA PHARMACEUTICALS CO2 citations71
US10202376B2Feb 12, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations70
US12421188B2Sep 23, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12415782B2Sep 16, 2025
Heterocyclic compound and use thereof
TAKEDA PHARMACEUTICALS CO0 citations62
US12404237B2Sep 2, 2025
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
TAKEDA PHARMACEUTICALS CO0 citations62
US10144743B2Dec 4, 2018
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations62
US12534471B2Jan 27, 2026
Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof
TAKEDA PHARMACEUTICALS CO0 citations59
US11987586B1May 21, 2024
Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists
TAKEDA PHARMACEUTICALS CO1 citations59
US11495331B2Nov 8, 2022
Document creation assistance server and document creation assistance method
TAKEDA PHARMACEUTICALS CO0 citations56
US10717748B2Jul 21, 2020
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO0 citations52
US9963443B2May 8, 2018
Radiolabeled compounds
TAKEDA PHARMACEUTICALS CO1 citations52
US12077522B2Sep 3, 2024
Heterocyclic compound and application thereof
TAKEDA PHARMACEUTICALS CO0 citations51
US10112956B2Oct 30, 2018
Heterocyclic compounds having cholesterol 24-hydroxylase activity
TAKEDA PHARMACEUTICALS CO1 citations51
US9624184B2Apr 18, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations51
US12448377B2Oct 21, 2025
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US12091410B2Sep 17, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US12071434B2Aug 27, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
TAKEDA PHARMACEUTICAL
9 patentsUS9193709B2Nov 24, 2015
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICAL8 citations92
US8871766B2Oct 28, 2014
Heterocyclic compounds
TAKEDA PHARMACEUTICAL8 citations92
US8865717B2Oct 21, 2014
Heterocyclic compounds
TAKEDA PHARMACEUTICAL8 citations92
US8648079B2Feb 11, 2014
Heterocyclic compounds
TAKEDA PHARMACEUTICAL13 citations92
US8030337B2Oct 4, 2011
Tricyclic compound and pharmaceutical use thereof
TAKEDA PHARMACEUTICAL4 citations73
US9296746B2Mar 29, 2016
Heterocyclic compound
TAKEDA PHARMACEUTICAL3 citations72
US8552037B2Oct 8, 2013
Tricyclic compound and pharmaceutical use thereof
TAKEDA PHARMACEUTICAL2 citations62
US8349879B2Jan 8, 2013
Tricyclic compound and pharmaceutical use thereof
TAKEDA PHARMACEUTICAL2 citations62
US8895591B2Nov 25, 2014
Tricyclic compound and pharmaceutical use thereof
TAKEDA PHARMACEUTICAL0 citations51
UCHIKAWA OSAMU
3 patentsKOIKE TATSUKI
3 patentsUS8110585B2Feb 7, 2012
Bicyclic compound and pharmaceutical use thereof
KOIKE TATSUKI2 citations59
US8901309B2Dec 2, 2014
Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
KOIKE TATSUKI0 citations49
US8822699B2Sep 2, 2014
Heterocyclic compound and use thereof
KOIKE TATSUKI0 citations49